The LTC Innovation Blog

Long-term care pharmacies are heading into one of the most significant reimbursement shifts in years. With the first set of medications entering the Medicare Drug Price Negotiation Program on January 1, 2026, LTC pharmacies must prepare now for the operational, financial, and clinical ripple effects that come with the introduction of the Maximum Fair Price (MFP) reimbursement framework.

Your team has worked diligently to prepare a barrage of medication orders, provided crucial clinical support to your long-term care (LTC) facilities, and built strong relationships with your patients. Yet, month after month, a significant chunk of your hard-earned revenue vanishes into the black hole of claim rejections. Sound familiar?